Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
0.9949
+0.0449 (4.73%)
Oct 29, 2026, 10:35 AM EDT - Market open
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $12.79 million as of October 29, 2026. Its market cap has decreased by 71.93% in one year.
Market Cap
12.79M
Enterprise Value
8.21M
1-Year Change
-71.93%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $12.79M, a decrease of -82.44%. That is a compound annual growth rate of -29.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 13.74M | -76.75% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 15.60M |
| Pluri | 15.18M |
| Allarity Therapeutics | 15.12M |
| Kiora Pharmaceuticals | 15.02M |
| Citius Pharmaceuticals | 14.85M |
| Dyadic International | 14.36M |
| BioCardia | 14.34M |
| TScan Therapeutics | 13.48M |